← All indications
Adrenocortical Carcinoma
A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
Drugs by status
Approved for this indication (1)
Phase 3 trials (6)
Phase 2 trials (37)
- 123i-iodometomidate
- atezolizumab
- antineoplaston a10
- urea
- sorafenib
- cixutumumab
- dovitinib
- paclitaxel
- gossypol
- lapatinib
- nivolumab
- pembrolizumab
- lenvatinib
- megestrol
- vincristine
- phenylacetic acid
- ipilimumab
- sunitinib
- bevacizumab
- suramin
- abiraterone
- tkm-080301
- dostarlimab
- acetic acid
- cabazitaxel
- cabozantinib
- gefitinib
- docetaxel
- sodium thiosulfate
- oxaliplatin
- +7 more
Phase 1 trials (19)
- atr-101
- colloidal gold-bound tumor necrosis factor
- prednisone
- aldesleukin
- cintredekin besudotox
- Eganelisib
- trastuzumab
- carboplatin
- interleukin-12
- seneca valley virus
- cyclophosphamide
- fludarabine
- relacorilant
- [225ac]-fpi-1434
- [111in]-fpi-1547
- il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells (Biological)
- [18f]ceto
- 68ga-r8760
- adct-701
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (11)
- Astellas
- National Cancer Institute (NCI)
- Julius-Maximilians University
- Collaborative Group for Adrenocortical Carcinoma Treatment
- Uppsala University
- University of Turin
- University of Texas at Houston
- University of Brescia
- German Federal Ministry of Education and Research
- European Network for the Study of Adrenal Tumors (ENS@T)
- Amercian Australian Asian Adrenal Alliance (A5)
Organization Involved with Phase 2 Indications (27)
- Bristol-Myers Squibb
- AstraZeneca
- Merck
- Exelixis
- Genentech
- Pfizer
- Novartis
- Arbutus Biopharma Corporation
- Enterome
- National Institutes of Health (NIH)
- Azienda Ospedaliera San Camillo Forlanini
- Burzynski Research Institute
- Cornell University
- Harvard University
- Dartmouth University
- Kentuckiana Cancer Institute
- Northwestern University
- Southwest Oncology Group
- Sichuan University
- Spanish Oncology Genito-Urinary Group
- University of Milan
- University of Ottawa
- Mayo Clinic
- Columbia University
- University of Chicago
- University of Cincinnati
- University of Copenhagen
Organization Involved with Phase 1 Indications (7)